LYELL IMMUNOPHARMA INC
LYELNASDAQ🏆 #2667 by market capEarnings Nov 11US Equity
$14.88▲ $0.57 (+3.84%)
Market closed · at close1h—
24h▲ 3.8%
7d—
14d—
30d—
1y—
🏦Market Cap
$365M
Small Cap
📈Revenue Growth (YoY)
-41.0%
Declining
📊Gross Margin
-8537.0%
Thin
💵FCF Margin
-639148.2%
Thin
⚖️P/S Ratio
13504.6x
Expensive
Otter Score
42
Weak
Earnings
Q3 · 2026Reported 2026-08-06Earnings Per Share
Actual
-1.92
Expected
-1.90
miss
−1.10%
YoY +33.60%
Revenue
Actual
$4.00K
Expected
$3.63K
beat
+10.30%
YoY −50.00%
Consensus estimates
Recent quarters
Q3 2026
-1.92
miss
Q2 2026
-1.10
beat
Q1 2026
-7.68
miss
Q4 2025
-2.13
beat